The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
Completed
- Conditions
- CancerInflammation
- Registration Number
- NCT01180907
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Brief Summary
The purpose of the study is to determine whether positron emission tomography using the new imaging agent 18F-FAC can be used for imaging cancer and/or inflammation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- > 18 years of age
- women of childbearing potential will undergo a pregnancy test free of charge
- patients with cancer or autoimmune diseases or healthy subjects
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UCLA
🇺🇸Los Angeles, California, United States